| Literature DB >> 30108894 |
Chun-Qi Hu1,2,3, Kang Li1,4, Ting-Ting Yao1, Yong-Zhou Hu1, Hua-Zhou Ying1, Xiao-Wu Dong1.
Abstract
A set of ninety-eight B-RafV600E inhibitors was used for the development of a molecular docking based QSAR model using linear and non-linear regression models. The integration of docking scores and key interaction profiles significantly improved the accuracy of the QSAR models, providing reasonable statistical parameters (Rtrain2 = 0.935, Rtest2 = 0.728 and QCV2 = 0.905). The established MD-SVR (molecular docking based SMV regression) model as well as model screening of a natural product database was carried out and two natural products (quercetin and myricetin) with good prediction activities were biologically evaluated. Both compounds exhibited promising B-RafV600E inhibitory activities (ICQuercetin50 = 7.59 μM and ICMyricetin50 = 1.56 μM), suggesting a high reliability and good applicability of the established MD-SVR model in the future development of B-RafV600E inhibitors with high efficacy.Entities:
Year: 2017 PMID: 30108894 PMCID: PMC6084233 DOI: 10.1039/c7md00229g
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597